Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin

Thrombosis and Haemostasis

Volumn 78, Issue 3, 1997, Pages 1021-1026

  Ray, Michael J ^a   Marsh, Neville A ^b  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; D DIMER; FIBRIN; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FIBRINOLYSIS; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030826772     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657680     Document Type: Article

References (27)

1. Blanchard A, Hurni M, Ruchat P, Stumpe F, Fischer A, Sadeghi H. Incidence of deep and superficial sternal infection after open heart surgery. A ten years retrospective study from 1981 to 1991. Eur J Cardiothorac Surg. 1995; 9: 153-7.
2. Gram J, Janetzko T, Jesperson J, Bruhn HD. Enhanced effective fibrinolysis following the neutralisation of heparin in open heart surgery increases the risk of post-surgical bleeding. Thromb Haemost 1990; 63: 241-5.
3. Teufelsbauer H, Proidl MH, Vukovich T. Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost 1992; 68: 250-2.
4. Orchard M, Goodchild C, Prentice C, Davies J, Benoit S, Creighton KL, Gaffney P, Michelson A. Aprotinin reduces cardiopulmonary bypass induced blood loss and inhibits fibrinolysis without influencing platelets. Br J Haematol. 1993; 85: 533-41.
5. Wahba A, Black G, Koksch M, Rothe G, Premier J, Schmitz G, Birnbaum DE. Aprotinin has no effect on platelet activation and adhesion during cardiopulmonary bypass. Thromb Haemost 1996; 75: 844-8.
6. Ray MJ, Marsh NA, Just SJE, Perrin EJ, O'Brien MF, Hawson GAT. Preoperative platelet dysfunction increases the benefit of aprotinin in cardiopulmonary bypass. Ann Thorac Surg 1997; 63: 57-63.
7. Ray MJ, Marsh NA, Hawson GAT. Relationship of fibrinolysis and platelet function to bleeding after cardiopulmonary bypass. Blood Coag Fibrinol 1994; 5: 679-85.
8. Tanaka K, Takao M, Yada I, Yuasa H, Kusagawa M. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. J Cardiothor Anaesth 1989; 3: 181-8.
9. Fuhrer G, Gallimore MJ, Heller W, Hoffmeister HE. Aprotinin in cardiopulmonary bypass - effects on the Hageman factor (FXII)-kallikrein system and blood loss. Blood Coag Fibrinol 1992; 3: 99-104.
10. Kongsgaard U, Smith-Erichsen N, Geiran O, Bjornskau L. Changes in the coagulation and fibrinolytic systems during and after cardiopulmonary bypass surgery. Thorac Cardiovasc Surg 1989; 37: 158-62.
11. Khuri S, Wolfe J, Josa M, et al. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg. 1992; 104: 94-107.
12. Dietrich W, Spannagl M, Jochum M, et al. Influence of high dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization. Anesthesiology 1990; 73: 1119-26.
13. Bidstrup B, Harrison J, Royston D, Taylor KM, Treasure T. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom. Ann Thorac Surg 1993; 55: 971-6.
14. Lavee J, Raviv Z, Smolinsky A, et al. Platelet protection by low dose aprotinin in cardiopulmonary bypass: electron microscopic study. Ann Thorac Surg 1993; 55: 114-9.
15. Havel M, Griesmacher A, Weigel G, et al. Aprotinin increases release of von Willebrand factor in cultured human umbilical vein endothelial cells. Surgery 1992; 112: 573-7.
16. Stibbe J, Kluft C, Brommer EJP, Gomes M, de Jong DS, Nauta J. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator. Eur J Clin Invest 1984; 14: 375-82.
17. Chandler WL, Fitch JCK, Wall MH, Verrier ED, Cochran RP, Soltow LO, Spiess BD. Individual variations in the fibrinolytic response during and after cardiopulmonary bypass. Thromb Haemost 1995; 74: 1293-7.
18. Chandler W. The effect of cardiopulmonary bypass on fibrin formation and lysis: Is a normal fibrinolytic response essential? J Cardiovasc Pharmacol 1996; 27: S63-8.
19. Royston D. Serine protease inhibition prevents both cellular and humoral responses to cardiopulmonary bypass. J Cardiovasc Pharmacol 1996; 27: S42-9.
20. Royston D. The serine antiprotease aprotinin (Trasylol™): a novel approach to reduce postoperative bleeding. Blood Coag Fibrinol; 1990; 1: 55-69.
21. Voss R, Matthias FR, Borkowski G, Reitz D. Activation and inhibition of fibrinolysis in septic patients in an internal intensive care unit. Br J Haematol 1990; 75: 99-105.
22. Longstaff C. Studies in the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coag Fibrinol 1994; 5: 537-42.
23. Dietrich W. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional action of aprotinin? J Cardiovasc Pharmacol 1996; 27: S50-7.
24. Broze GJ. Tissue factor pathway inhibitor. Thromb Haemost 1995; 74: 90-3.
25. Boisclair MD, Lane DA, Philippou H, Esnouf MP, Sheikh S, Hunt B, Smith KJ. Mechanisms of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993; 82: 3350-7.
26. Francis JL, Howard C. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin. Blood Coag Fibrinol 1993; 4: 35-40.
27. Dietrich W, Dilthey G, Spannagl M, Jochum M, Braun SL, Richter JA. Influence of high-dose aprotinin on anticoagulation, heparin requirement, and celite- and kaolin-activated clotting time in heparin-pretreated patients undergoing open-heart surgery. A double-blind, placebo-controlled study. Anesthesiology 1995; 83: 679-89.